Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Biomarkers in Sepsis Associated Encephalopathy (SAE)

NCT03133208 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT03133208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Biomarkers in Sepsis Associated Encephalopathy (SAE)
Lead sponsor
University of Florida
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2017
Completion date
December 15, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

altered mental status, delirium, sepsis associated, sepsis, sepsis associated encephalopathy, sepsis-associated delirium